rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    ANIX
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Anixa Biosciences Announces Completion of Treatment of Fifth Cohort in its Ovarian Cancer CAR-T Clinical Trial
      Oct 26Yahoo FinanceANIX
      Anixa Biosciences president, COO, & CFO buys $15,620 in shares
      Oct 25Investing.comANIX
      Anixa Biosciences CEO Amit Kumar buys $21,760 in stock
      Oct 22Investing.comANIX
      Join Anixa Biosciences' Live Investor Webinar: Advancing Innovative CAR-T Therapy for Ovarian Cancer and a First-in-Class Breast Cancer Vaccine
      Oct 13Yahoo FinanceANIX
      Analysts Conflicted on These Healthcare Names: Alcon (ALC), BioNTech SE (BNTX) and Anixa Biosciences (ANIX)

      Detailed price information for Biontech Se ADR (BNTX-Q) from The Globe and Mail including charting and trades.

      Oct 7The Globe and MailANIX
      H.C. Wainwright reiterates Buy on Anixa stock, $6 target on trial data
      Oct 6Investing.comANIX
      Anixa Biosciences Announces Treatment of Second Patient in the Fifth Cohort of its Ovarian Cancer CAR-T Clinical Trial
      Oct 1MorningstarANIX
      Anixa Biosciences CEO Amit Kumar buys $19,460 in common stock
      Sep 28Investing.comANIX
      Anixa Biosciences director buys $13,799 in ANIX stock
      Sep 28Investing.comANIX
      Anixa Biosciences director Lewis Titterton Jr. buys $131,906 in stock
      Sep 25Investing.comANIX
      H.C. Wainwright lowers Anixa Biosciences stock price target to $6
      Sep 23Investing.comANIX
      Anixa Biosciences Granted First Australian Patent for its Breast Cancer Vaccine, Broadening Global Protection Through 2040
      Sep 21MorningstarANIX
      Anixa Biosciences adds UPenn oncologist to advisory board
      Sep 16Investing.comANIX
      Anixa Biosciences Appoints UPenn's Dr. Carmen Guerra to Cancer Business Advisory Board

      Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced the appointment of Carmen Guerra, M.D., M.S.C.E., F.A.C.P., to its Cancer Business Advisory Board.

      Sep 16Yahoo FinanceANIX
      Anixa Biosciences CEO Amit Kumar buys $8,250 in ANIX common stock
      Sep 14Investing.comANIX
      Anixa Biosciences director Lewis Titterton Jr. buys $27,300 in stock
      Sep 14Investing.comANIX
      Anixa Biosciences CEO Amit Kumar acquires $13,799 in stock
      Sep 11Investing.comANIX
      Anixa Biosciences and Nexalin Technology Interviews to Air Nationally on the RedChip Small Stocks, Big Money(TM) Show on CNBC and Bloomberg TV

      ORLANDO, FL / ACCESS Newswire / September 11, 2026 / RedChip Companies will air interviews with Anixa Biosciences Inc. (NASDAQ:ANIX) and Nexalin Technology Inc.

      Sep 11Yahoo FinanceANIXNXL
      Anixa Biosciences at H.C. Wainwright: two cancer bets advance
      Sep 11Investing.comANIX
      Anixa Biosciences Interview Highlighting Breast Cancer Vaccine to Air on the RedChip Small Stocks, Big Money™ Show on Bloomberg TV
      Sep 9MorningstarANIX
      Anixa Biosciences to Present at the Nasdaq & LD Micro Inaugural SF Summit on September 9, 2026
      Sep 3MorningstarANIX
      Anixa Biosciences to Present at the 2026 Cantor Fitzgerald Global Healthcare Conference Highlighting its Breast Cancer Vaccine and Ovarian Cancer CAR-T Therapy
      Aug 24MorningstarANIX

      This is the newest page. Registered accounts read further back.